购物车
- 全部删除
- 您的购物车当前为空
ARV-825 是一种双功能 PROTAC,蛋白水解靶向嵌合体,将 BRD4 募集到 E3 泛素连接酶大脑中,导致 BRD4 在所有测试的 BL 细胞系中快速、有效和延长降解。对 BRD4 的 BD1 和 BD2 结构域具有高亲和力,Kd 值分别为 90 和 28 nM。
为众多的药物研发团队赋能,
让新药发现更简单!
ARV-825 是一种双功能 PROTAC,蛋白水解靶向嵌合体,将 BRD4 募集到 E3 泛素连接酶大脑中,导致 BRD4 在所有测试的 BL 细胞系中快速、有效和延长降解。对 BRD4 的 BD1 和 BD2 结构域具有高亲和力,Kd 值分别为 90 和 28 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 456 | 现货 | |
5 mg | ¥ 987 | 现货 | |
10 mg | ¥ 1,680 | 现货 | |
25 mg | ¥ 2,970 | 现货 | |
50 mg | ¥ 4,390 | 现货 | |
100 mg | ¥ 6,290 | 现货 |
产品描述 | ARV-825, a heterobifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon leading to fast, efficient, and prolonged degradation of BRD4 in all BL cell lines tested. |
靶点活性 | BRD4 BD1:90 nM (Kd), BRD4 BD2:28 nM (Kd) |
体外活性 | ARV-825 在抑制 c-MYC 水平和下游信号传导方面比小分子 BRD4 抑制剂更有效,导致在BL中细胞增殖抑制和凋亡诱导更为有效。在Burkitt's lymphoma细胞中,ARV-825 降低 c-Myc 水平,阻止细胞增殖,并诱导凋亡。 |
细胞实验 | Cells (50000/100ul) were seeded in 96-well tissue culture plates followed by addition of ARV-825?at indicated concentration.?After 72 hours, 100 μL per well of reconstituted CellTiter-Glo reagent was added and read on Cytation 3 imaging reader.?Relative cell growth was determined by comparing assay readings of treated cells with control DMSO treated cells.?For apoptosis induction, Caspase-Glo 3/7 Assay was used following manufacturer s instruction. |
分子量 | 923.43 |
分子式 | C46H47ClN8O9S |
CAS No. | 1818885-28-7 |
Smiles | CC=1C2=C(N3C([C@H](CC(NC4=CC=C(OCCOCCOCCOCCNC5=C6C(C(=O)N(C6=O)C7C(=O)NC(=O)CC7)=CC=C5)C=C4)=O)N=C2C8=CC=C(Cl)C=C8)=NN=C3C)SC1C |
密度 | 1.47 g/cm3 (Predicted) |
存储 | store at low temperature,store under nitrogen,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (54.15 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容